Cargando…

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike

Current SARS-CoV-2 vaccines are effective, but long-term protection is threatened by the emergence of virus variants. We generated a virosome vaccine containing the Beta spike protein and compared its immunogenicity in mice to a virosome vaccine containing the original Wuhan spike. Two administratio...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Velden, Yme U., Grobben, Marloes, Caniels, Tom G., Burger, Judith A., Poniman, Meliawati, Oomen, Melissa, Rijnstra, Esther Siteur-van, Tejjani, Khadija, Guerra, Denise, Kempers, Ronald, Stegmann, Toon, van Gils, Marit J., Sanders, Rogier W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913678/ https://www.ncbi.nlm.nih.gov/pubmed/35273217 http://dx.doi.org/10.1038/s41598-022-07590-w

Ejemplares similares

A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
por: Brinkkemper, Mitch, et al.
Publicado: (2021)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
por: Brinkkemper, Mitch, et al.
Publicado: (2022)

Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice
por: Espíndola, Otávio de Melo, et al.
Publicado: (2021)

Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate
por: Fernandes, Bárbara, et al.
Publicado: (2022)

Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice
por: van der Velden, Yme U., et al.
Publicado: (2020)

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
por: Brouwer, Philip J.M., et al.
Publicado: (2021)

A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
por: Claireaux, Mathieu, et al.
Publicado: (2022)

Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
por: van Gils, Marit J., et al.
Publicado: (2022)

Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
por: Kamphuis, Tobias, et al.
Publicado: (2012)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
por: Radić, Laura, et al.
Publicado: (2023)

Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)

A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats
por: Kamphuis, Tobias, et al.
Publicado: (2013)

Decreased breadth of the antibody response to the spike protein of SARS-CoV-2 after repeated vaccination
por: Horndler, Lydia, et al.
Publicado: (2023)

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
por: Schriek, Angela I., et al.
Publicado: (2022)

Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
por: Derking, Ronald, et al.
Publicado: (2021)

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
por: van Schooten, Jelle, et al.
Publicado: (2018)

Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability
por: Lederhofer, J., et al.
Publicado: (2018)

Enhanced HPV16 E6/E7(+) tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides
por: Stegmann, Toon, et al.
Publicado: (2023)

Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
por: van Rijswijck, Danique M. H., et al.
Publicado: (2022)

Feasibility of high‐density electric source imaging in the presurgical workflow: Effect of number of spikes and automated spike detection
por: Heide, Ev‐Christin, et al.
Publicado: (2023)

A Rate-Reduced Neuron Model for Complex Spiking Behavior
por: Dijkstra, Koen, et al.
Publicado: (2017)

Virosome: An engineered virus for vaccine delivery
por: Ali, Hasan, et al.
Publicado: (2023)

A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern
por: van Gils, Marit J., et al.
Publicado: (2021)

The effect of spike time dependent plasticity on activity patterns in the basal ganglia
por: Lourens, Marcel AJ, et al.
Publicado: (2011)

Spike-timing-dependent plasticity steers new Parkinson-stimulation protocols
por: Lourens, Marcel AJ, et al.
Publicado: (2013)

Phase-locking of epileptic spikes to ongoing delta oscillations in non-convulsive status epilepticus
por: Hindriks, Rikkert, et al.
Publicado: (2013)

Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
por: Yin, Victor, et al.
Publicado: (2021)

New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes
por: Amacker, Mario, et al.
Publicado: (2020)

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
por: Verburgh, Myrthe L., et al.
Publicado: (2023)

Serial Spike Time Correlations Affect Probability Distribution of Joint Spike Events
por: Shahi, Mina, et al.
Publicado: (2016)

ABX464: a good drug candidate instead of a magic bullet
por: Berkhout, Ben, et al.
Publicado: (2015)

Spiked Helmet or Spiked Electrode?
por: Aslanger, Emre, et al.
Publicado: (2021)

Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
por: Rodriguez-Aponte, Sergio A., et al.
Publicado: (2023)

Differences in systemic and mucosal SARS-CoV-2 antibody prevalence in a prospective cohort of Dutch children
por: Keuning, Maya W., et al.
Publicado: (2022)

Spike to spike MT model and applications
por: Escobar, Maria-Jose, et al.
Publicado: (2007)

Learning to represent signals spike by spike
por: Brendel, Wieland, et al.
Publicado: (2020)

Reply: Spiked Helmet or Spiked Electrode?
por: De Bernardi, Claudio, et al.
Publicado: (2021)

The Full Breadth of Mendel’s Genetics
por: van Dijk, Peter J., et al.
Publicado: (2016)

Uncovering Neuronal Networks Defined by Consistent Between-Neuron Spike Timing from Neuronal Spike Recordings
por: van der Meij, Roemer, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_91nh221vfuqi75ih6a0g50dtc0